Clopidogrel
Plavix (clopidogrel) is a prescription medication that helps prevent blood clots by inhibiting platelet aggregation. It's available as oral tablets in 75 mg and 300 mg strengths, manufactured by Sanofi-Aventis U.S. LLC. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Plavix (clopidogrel) is a prescription medication that helps prevent blood clots by inhibiting platelet aggregation. It's available as oral tablets in 75 mg and 300 mg strengths, manufactured by Sanofi-Aventis U.S. LLC. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Clopidogrel", "mediaType": "text/html", "description": " Access the FDA dataset for Clopidogrel — ANDA 020839 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020839" } ] |
| identifier | ANDA020839 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "fda", "health-care", "medications", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Clopidogrel |
